All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Performance comparison

MK-677 (Ibutamoren) vs Tesamorelin

An educational, source-based comparison of MK-677 (Ibutamoren) and Tesamorelin — how each peptide works, what it's researched for, and what to know before going deeper.

Growth Hormone Axis · Small Molecule
MK-677 (Ibutamoren)

Orally bioavailable non-peptide ghrelin mimetic.

Mechanism

Technically a small-molecule ghrelin receptor agonist (not a peptide), often grouped with peptide GH research. Orally bioavailable, it elevates GH and IGF-1 over 24 hours and increases appetite.

Research areas
  • GH/IGF-1 elevation in adults
  • Lean mass and bone density in elderly
  • Sleep quality (slow-wave sleep)
Considerations
  • Not FDA-approved.
  • Insulin resistance and fluid retention reported.
  • Banned by WADA.
Full MK-677 (Ibutamoren) profile →
Growth Hormone Axis
Tesamorelin

GHRH analog FDA-approved for HIV-associated visceral fat.

Mechanism

A stabilized analog of growth hormone-releasing hormone (GHRH) that stimulates pulsatile endogenous GH and IGF-1 release. FDA-approved (Egrifta) for the reduction of excess abdominal visceral fat in HIV-infected patients with lipodystrophy.

Research areas
  • Visceral adipose tissue reduction (approved)
  • Cognitive function in older adults (research)
  • NAFLD / hepatic fat (research)
Considerations
  • FDA-approved only for HIV-associated lipodystrophy.
  • May affect glucose tolerance; monitor in at-risk patients.
  • Requires physician oversight.
Full Tesamorelin profile →

MK-677 (Ibutamoren) vs Tesamorelin — Key differences

  • Class: MK-677 (Ibutamoren) is classified as Growth Hormone Axis · Small Molecule, while Tesamorelin is Growth Hormone Axis.
  • Primary research focus: MK-677 (Ibutamoren)gh/igf-1 elevation in adults; Tesamorelinvisceral adipose tissue reduction (approved).
  • Tag: Growth hormone · Oral vs Body composition.

Related comparisons